Literature DB >> 29142484

Contemporary Management of Pulmonary Arteriovenous Malformations.

Nicholas Rauh1, John Gurley2, Sibu Saha3.   

Abstract

Pulmonary arteriovenous malformations (PAVMs) are atypical vascular structures involving a direct connection between the pulmonary arterial and venous circulations. While PAVMs are a relatively uncommon disorder, unmanaged cases are at risk for the development of serious complications including embolization and infection. Since their first description in 1897, PAVMs have been identified and treated in a variety of ways. Advancements in diagnostic methods and operative techniques have allowed for more effective treatment of the disease. Most recently, the use of vascular plug transcatheter embolization has been described as an effective therapeutic procedure in the management of PAVMs. In this report, we present our experience with nine cases of PAVMs treated at the University of Kentucky, including special consideration of an exemplary case that illustrates the typical course of treatment for the disease.

Entities:  

Keywords:  chest CT; coil embolization; hereditary hemorrhagic telangiectasia; pulmonary angiography; pulmonary arteriovenous malformations; transcatheter embolization therapy; vascular plug embolization

Year:  2017        PMID: 29142484      PMCID: PMC5685787          DOI: 10.1055/s-0037-1607033

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  40 in total

1.  Congenital pulmonary arteriovenous aneurysm.

Authors:  R D SLOAN; R N COOLEY
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1953-08

Review 2.  PAVM embolization: an update.

Authors:  Scott O Trerotola; Reed E Pyeritz
Journal:  AJR Am J Roentgenol       Date:  2010-10       Impact factor: 3.959

3.  Surgical treatment of recurrent transient ischemic attacks and hemoptysis in a young man with multiple pulmonary arteriovenous malformations.

Authors:  Cliff K Choong; Daniel M Goodenberger; Daniel Picus; Bryan F Meyers
Journal:  J Thorac Cardiovasc Surg       Date:  2005-11       Impact factor: 5.209

4.  Pulmonary arteriovenous fistula. Diagnosis and prognosis in noncomplainant patients.

Authors:  H Sluiter-Eringa; N G Orie; H J Sluiter
Journal:  Am Rev Respir Dis       Date:  1969-08

5.  Pulmonary arteriovenous fistulas.

Authors:  M R Gomes; P E Bernatz; D E Dines
Journal:  Ann Thorac Surg       Date:  1969-06       Impact factor: 4.330

6.  Clinical and radiological long-term follow-up after embolization of pulmonary arteriovenous malformations.

Authors:  Poul Erik Andersen; Anette D Kjeldsen
Journal:  Cardiovasc Intervent Radiol       Date:  2006 Jan-Feb       Impact factor: 2.740

7.  Pulmonary arteriovenous malformations: cerebral ischemia and neurologic manifestations.

Authors:  M Moussouttas; P Fayad; M Rosenblatt; M Hashimoto; J Pollak; K Henderson; T Y Ma; R I White
Journal:  Neurology       Date:  2000-10-10       Impact factor: 9.910

8.  Pulmonary arteriovenous malformations: therapeutic options.

Authors:  J D Puskas; M S Allen; A C Moncure; J C Wain; A D Hilgenberg; C Wright; H C Grillo; D J Mathisen
Journal:  Ann Thorac Surg       Date:  1993-08       Impact factor: 4.330

9.  Prevalence of pulmonary arteriovenous malformations as estimated by low-dose thoracic CT screening.

Authors:  Masayuki Nakayama; Takeshi Nawa; Tatsuya Chonan; Katsuyuki Endo; Satoshi Morikawa; Masashi Bando; Yasuhiko Wada; Takanobu Shioya; Yukihiko Sugiyama; Shimao Fukai
Journal:  Intern Med       Date:  2012-07-01       Impact factor: 1.271

10.  Hemorrhage-adjusted iron requirements, hematinics and hepcidin define hereditary hemorrhagic telangiectasia as a model of hemorrhagic iron deficiency.

Authors:  Helen Finnamore; James Le Couteur; Mary Hickson; Mark Busbridge; Kevin Whelan; Claire L Shovlin
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

View more
  2 in total

1.  Pitfalls of delaying the diagnosis of hereditary haemorrhagic telangiectasia.

Authors:  Tamás Major; Csaba Csobay-Novák; Réka Gindele; Zsuzsanna Szabó; László Bora; Natália Jóni; Tamás Rácz; Tamás Karosi; Zsuzsanna Bereczky
Journal:  J Int Med Res       Date:  2019-09-11       Impact factor: 1.671

2.  Targeting Nanoparticles to Bioengineered Human Vascular Networks.

Authors:  Kathleen Cullion; Laura C Petishnok; Hyunji Koo; Brendan Harty; Juan M Melero-Martin; Daniel S Kohane
Journal:  Nano Lett       Date:  2021-07-23       Impact factor: 12.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.